Hyaluronan reduces inflammation in experimental arthritis by modulating TLR-2 and TLR-4 cartilage expression

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 9, 2011, Pages 1170-1181

  Campo, Giuseppe M ^a   Avenoso, Angela ^a   Nastasi, Giancarlo ^a   Micali, Antonio ^a   Prestipino, Vera ^a   Vaccaro, Mario ^a   D'Ascola, Angela ^a   Calatroni, Alberto ^a   Campo, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Arthritis; Cytokine; Hyaluronan; NF kB; TNF alpha; Toll like receptor

Indexed keywords

COLLAGEN TYPE 2; COLLAGENASE 3; HYALURONIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 17; INTERLEUKIN 1BETA; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CARTILAGE; CONTROLLED STUDY; HISTOLOGY; IMMUNOMODULATION; INFLAMMATION; JOINT; MALE; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE; COLLAGEN TYPE II; HYALURONIC ACID; INFLAMMATION; MICE; MICE, INBRED DBA; MOLECULAR WEIGHT; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; SYNOVIAL FLUID; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

BOVINAE; MUS;

EID: 79960559540     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.06.006     Document Type: Article

References (54)

1. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 358:903-911.
2. Goldring M.B., Marku K.B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res. Ther. 2009, 11:224.
3. Ospelt C., Gay S. The role of resident synovial cells in destructive arthritis. Best Pract. Res. Clin. Rheumatol. 2008, 22:239-252.
4. Roelofs M.F., Joosten L.A., Abdollahi-Roodsaz S., van Lieshout A.W., Sprong T., van den Hoogen F.H., van den Berg W.B., Radstake T.R. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4 and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum. 2005, 52:2313-2322.
5. Roelofs M.F., Wenink M.H., Brentano F., Abdollahi-Roodsaz S., Oppers-Walgreen B., Barrera P., van Riel P.L., Joosten L.A., Kyburz D., van den Berg W.B., Radstake T.R. Type I interferons might form the link between toll-like receptors (TLR) 3/7 and TLR4 mediated synovial inflammation in rheumatoid arthritis (RA). Ann. Rheum. Dis. 2009, 68:1486-1493.
6. Ospelt C., Brentano F., Rengel Y., Stanczyk J., Kolling C., Tak P.P., Gay R.E., Gay S., Kyburz D. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis. Arthritis Rheum. 2008, 58:3684-3692.
7. Kim H.A., Cho M.L., Choi H.Y., Yoon C.S., Jhun J.Y., Oh H.J., Kim H.I. The catabolic pathway mediated by toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 2006, 54:2152-2163.
8. Kim K.W., Cho M.L., Lee S.H., Oh H.J., Kang C.M., Ju J.H., Min S.Y., Cho Y.G., Park S.H., Kim H.Y. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol. Lett. 2007, 110:54-64.
9. Huang Q., Adebayo A., Pope R.M. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum. 2007, 56:2192-2201.
10. Fraser J.R., Laurent T.C., Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 1997, 242:27-33.
11. Teder P., Vandivier R.W., Jiang D., Liang J., Cohn L., Purè E., Henson P.M., Noble P.W. Resolution of lung inflammation by CD44. Science 2002, 296:155-158.
12. Nobel P.W., McKee C.M., Cowman M., Shin H.S. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J. Exp. Med. 1996, 183:2373-2378.
13. Termeer C., Hennies J., Voith U., Ahrens T., Weiss J.M., Prehm P., Simon J.C. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 2000, 165:1863-1870.
14. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006, 6:823-835.
15. Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., Prestwich G.D., Mascarenhas M.M., Garg H.G., Quinn D.A., Homer R.J., Goldstein D.R., Bucala R., Lee P.J., Medzhitov R., Noble P.W. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 2005, 11:1173-1179.
16. Stern R., Asari A.A., Sugahara K.N. Hyaluronan fragments: an information-rich system. Eur. J. Cell Biol. 2006, 85:699-715.
17. Gariboldi S., Palazzo M., Zanobbio L., Selleri S., Sommariva M., Sfondrini L., Cavicchini S., Balsari A., Rumio C. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J. Immunol. 2008, 181:2103-2110.
18. Campo G.M., Avenoso A., Campo S., D'Ascola A., Nastasi G., Calatroni A. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie 2010, 92:204-215.
19. Pauloin T., Dutot M., Joly F., Warnet J.M., Rat P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol. Vis. 2009, 15:577-583.
20. Singleton P.A., Mirzapoiazova T., Guo Y., Sammani S., Mambetsariev N., Lennon F.E., Moreno-Vinasco L., Garcia J.G. High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:639-651.
21. Campo G.M., Avenoso A., Micali A., Nastasi G., Squadrito F., Altavilla D., Bitto A., Polito F., Rinaldi M.G., Calatroni A., D'Ascola A., Campo S. High-molecular weight hyaluronan reduced renal PKC activation in genetically diabetic mice. Biochim. Biophys. Acta 2010, 1802:1118-1130.
22. Hashizume M., Mihara M. High molecular weight hyaluronic acid inhibits IL-6-induced MMP production from human chondrocytes by up-regulating the ERK inhibitor, MKP-1. Biochem. Biophys. Res. Commun. 2010, 403:184-189.
23. Gigante A., Callegari L. The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis. Rheumatol. Int. 2011, 31:427-444.
24. Galeano M., Polito F., Bitto A., Irrora N., Campo G.M., Avenoso A., Calò M., Cascio P.L., Minutoli L., Barone M., Squadrito F. Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice. Biochim. Biophys. Acta 2011, 1812:752-759.
25. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 2007, 23:435-461.
26. Campo G.M., Avenoso A., Campo S., Traina P., D'Ascola A., Calatroni A. Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. Arch. Biochem. Biophys. 2009, 491:7-15.
27. Campo G.M., Avenoso A., Campo S., Ferlazzo A.M., Altavilla D., Calatroni A. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res. Ther. 2003, 5:R122-R131.
28. Campo G.M., Avenoso A., Campo S., Ferlazzo A.M., Altavilla D., Micali C., Calatroni A. Aromatic trap analysis of free radicals production in experimental collagen-induced arthritis in the rat: protective effect of glycosaminoglycans treatment. Free. Radic. Res. 2003, 37:257-268.
29. Lee H.G., Cowman M.K. An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal. Biochem. 1994, 219:278-287.
30. van Lent P.L., Grevers L., Lubberts E., de Vries T.J., Nabbe K.C., Verbeek S., Oppers B., Sloetjes A., Blom A.B., van den Berg W.B. Fcγ receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation. Arthritis Rheum. 2006, 54:3868-3877.
31. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
32. Seibl R., Birchler T., Loeliger S., Hossle J.P., Gay R.E., Saurenmann T., Michel B.A., Seger R.A., Gay S., Lauener R.P. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am. J. Pathol. 2003, 162:1221-1227.
33. Radstake T.R., Roelofs M.F., Jenniskens Y.M., Oppers-Walgreen B., van Riel P.L., Barrera P., Joosten L.A., van den Berg W.B. Expression of Toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-γ. Arthritis Rheum. 2004, 50:3856-3865.
34. Watters T.M., Kenny E.F., O'Neill L.A. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol. Cell Biol. 2007, 85:411-419.
35. Kenny E.F., O'Neill L.A. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008, 43:342-349.
36. Kawai T., Akira S. Toll-like receptor and RIG-1-like receptor signalling. Ann. N. Y. Acad. Sci. 2008, 1143:1-20.
37. Ghosh S., Hayden M.S. New regulators of NF-kappaB, in inflammation. Nat. Rev. Immunol. 2008, 8:837-848.
38. Goldring M.B., Marcu K.B. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res. Ther. 2009, 11:224.
39. Joesten L.A., Koenders M.I., Smeets R.L., Heuvelmans-Jacobs M., Helsen M.M., Takeda K., Akira S., Lubberts E., van de Loo F.A., van den Berg W.B. Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88. J. Immunol. 2003, 171:6145-6153.
40. Zare F., Bokarewa M., Nononen N., Bergstrom T., Alexopoulou L., Flavell R.A., Tarkowski A. Arthritogenic properties of double-stranded (viral) RNA. J. Immunol. 2004, 172:5656-5663.
41. Yoshino S., Yamaki K., Taneda S., Yanagisawa R., Takano H. Reactivation of antigen-induced arthritis in mice by oral administration of lipopolysaccharide. Scand. J. Immunol. 2005, 62:117-122.
42. Yoshino S., Ohsawa M. The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice. Br. J. Pharmacol. 2000, 129:1309-1314.
43. Johnson G.B., Brunn G.J., Kodaira Y., Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulphate by Toll-like receptor 4. J. Immunol. 2002, 168:5233-5239.
44. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., Chow J.C., Strauss J.F. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 2001, 276:10229-10233.
45. Schaefer L., Babelova A., Kiss E., Hausser H.J., Baliova M., Krzyzankova M., Marsche G., Young M.F., Mihalik D., Götte M., Malle E., Schaefer R.M., Gröne H.J. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 2005, 115:2223-2233.
46. Abdollahi-Roodsaz S., Joosten L.A., Roelofs M.F., Radstake T.R., Matera G., Popa C., van der Meer J.W., Netea M.G., van den Berg W.B. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum. 2007, 56:2957-2967.
47. van den Berg W.B., van Lent P.L., Joosten L.A., Abdollahi-Roodsaz S., Koenders M.I. Amplifying elements of arthritis and joint destruction. Ann. Rheum. Dis. 2007, 66(suppl. 3):45-48.
48. Bastow E.R., Byers S., Golub S.B., Clarkin C.E., Pitsilliders A.A., Fosang A.J. Hyaluronan synthesis and degradation in cartilage and bone. Cell. Mol. Life Sci. 2008, 65:395-413.
49. Moreland L.W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanism of action. Arthritis Res. Ther. 2003, 5:54-67.
50. Yates E.A., Terry C.J., Rees C., Rudd T.R., Duchesne L., Skidmore M.A., Lévy R., Thanh N.T., Nichols R.J., Clarke D.T., Fernig D.G. Protein-GAG interactions: new surface-based techniques, spectroscopies and nanotechnology probes. Biochem. Soc. Trans. 2006, 34:427-430.
51. Scheibner K.A., Lutz M.A., Boodoo S., Fenton M.J. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 2006, 177:1272-1281.
52. Adair-Kirk T.L., Senior S.M. Fragments of extracellular matrix as mediators of inflammation. Int. J. Biochem. Cell Biol. 2008, 40:1101-1110.
53. Voelcker V., Gebhardt C., Averbeck M., Saalbach A., Wolf V., Weih F., Sleeman J., Anderegg U., Simon J. Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp. Dermatol. 2008, 17:100-107.
54. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003, 425:516-521.